Annual Long Term Debt
$78.33 M
+$64.94 M+484.89%
31 December 2023
Summary:
Kymera Therapeutics annual long term debt is currently $78.33 million, with the most recent change of +$64.94 million (+484.89%) on 31 December 2023. During the last 3 years, it has risen by +$63.60 million (+431.69%). KYMR annual long term debt is now at all-time high.KYMR Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$75.38 M
-$385.00 K-0.51%
30 September 2024
Summary:
Kymera Therapeutics quarterly long term debt is currently $75.38 million, with the most recent change of -$385.00 thousand (-0.51%) on 30 September 2024. Over the past year, it has dropped by -$1.87 million (-2.42%). KYMR quarterly long term debt is now -3.76% below its all-time high of $78.33 million, reached on 31 December 2023.KYMR Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KYMR Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +484.9% | -2.4% |
| 3 y3 years | +431.7% | +409.0% |
| 5 y5 years | +10000.0% | - |
KYMR Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +484.9% | -3.8% | +474.5% |
| 5 y | 5 years | at high | >+9999.0% | -3.8% | +474.5% |
| alltime | all time | at high | >+9999.0% | -3.8% | +474.5% |
Kymera Therapeutics Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $75.38 M(-0.5%) |
| June 2024 | - | $75.77 M(-1.8%) |
| Mar 2024 | - | $77.13 M(-1.5%) |
| Dec 2023 | $78.33 M(+484.9%) | $78.33 M(+1.4%) |
| Sept 2023 | - | $77.25 M(+8.4%) |
| June 2023 | - | $71.26 M(+9.9%) |
| Mar 2023 | - | $64.86 M(+384.3%) |
| Dec 2022 | $13.39 M | $13.39 M(+2.1%) |
| Sept 2022 | - | $13.12 M(-3.8%) |
| June 2022 | - | $13.63 M(-1.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $13.90 M(-3.2%) |
| Dec 2021 | $14.36 M(-2.5%) | $14.36 M(-3.0%) |
| Sept 2021 | - | $14.81 M(-0.2%) |
| June 2021 | - | $14.84 M(+2.9%) |
| Mar 2021 | - | $14.42 M(-2.1%) |
| Dec 2020 | $14.73 M(-17.3%) | $14.73 M(-2.3%) |
| Sept 2020 | - | $15.08 M(-2.1%) |
| June 2020 | - | $15.40 M(-13.6%) |
| Dec 2019 | $17.82 M(+4433.3%) | $17.82 M |
| Dec 2018 | $393.00 K | - |
FAQ
- What is Kymera Therapeutics annual long term debt?
- What is the all time high annual long term debt for Kymera Therapeutics?
- What is Kymera Therapeutics annual long term debt year-on-year change?
- What is Kymera Therapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for Kymera Therapeutics?
- What is Kymera Therapeutics quarterly long term debt year-on-year change?
What is Kymera Therapeutics annual long term debt?
The current annual long term debt of KYMR is $78.33 M
What is the all time high annual long term debt for Kymera Therapeutics?
Kymera Therapeutics all-time high annual long term debt is $78.33 M
What is Kymera Therapeutics annual long term debt year-on-year change?
Over the past year, KYMR annual long term debt has changed by +$64.94 M (+484.89%)
What is Kymera Therapeutics quarterly long term debt?
The current quarterly long term debt of KYMR is $75.38 M
What is the all time high quarterly long term debt for Kymera Therapeutics?
Kymera Therapeutics all-time high quarterly long term debt is $78.33 M
What is Kymera Therapeutics quarterly long term debt year-on-year change?
Over the past year, KYMR quarterly long term debt has changed by -$1.87 M (-2.42%)